ArticleJAAD international2026

Anti-polymyositis/scleroderma antibody-positive myositis exhibits greater cutaneous T cell activation than anti-ARS antibody-positive myositis.

Norika Akashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.